BioXell agrees to Cosmo's acquisition offer
This article was originally published in Scrip
Executive Summary
Cosmo Pharmaceuticals has offered to acquire fellow Italian firm BioXell for CHF41.3 million (€27.4 million) in a move supported by BioXell.